Literature DB >> 26939559

Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review.

T Ivanova1, A Jalil1, Y Antoniou1, P N Bishop1,2, J L Vallejo-Garcia1,3, N Patton1.   

Abstract

Floaters are a common ocular condition which form as a consequence of aging changes in the vitreous. Although in most patients the symptoms are minimal, they can cause significant impairment in vision-related quality of life in a small population of patients. Recently there has been an increase in awareness of the visual disability caused by floaters, and the evidence-base for treatment of this condition using small-gauge vitrectomy has increased. In this review, we define the term 'floaters' as symptomatic vitreous opacities (SVO). We suggest a classification dependent on the presence or absence of posterior vitreous detachment and discuss their pathogenesis and natural history. We review their impact on patients' quality of life related to visual function. We review the psychological factors that may have a role in some patients who appear to be affected by SVO to the extent that they pursue all options including surgery with all its attendant risks. We summarise the available evidence-base of treatment options available for SVO with special emphasis on the safety and efficacy of vitrectomy for this condition.

Entities:  

Mesh:

Year:  2016        PMID: 26939559      PMCID: PMC4869141          DOI: 10.1038/eye.2016.30

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  50 in total

1.  Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group RAeport no. 1.

Authors:  Eric Ezra; Zdenek J Gregor
Journal:  Arch Ophthalmol       Date:  2004-02

2.  Age-related changes on the surface of vitreous collagen fibrils.

Authors:  Paul N Bishop; David F Holmes; Karl E Kadler; David McLeod; Kees Jan Bos
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-04       Impact factor: 4.799

3.  Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.

Authors:  Y M Delaney; A Oyinloye; L Benjamin
Journal:  Eye (Lond)       Date:  2002-01       Impact factor: 3.775

4.  Q-switched neodymium: YAG laser surgery of the vitreous.

Authors:  H L Little; R L Jack
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

5.  Neodymium:YAG laser vitreolysis.

Authors:  D Aron-Rosa; D A Greenspan
Journal:  Int Ophthalmol Clin       Date:  1985

6.  Vitrectomy: a pars plana approach.

Authors:  R Machemer; H Buettner; E W Norton; J M Parel
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1971 Jul-Aug

7.  [Pars plana vitrectomy for idiopathic vitreous floaters].

Authors:  M Roth; P Trittibach; F Koerner; G Sarra
Journal:  Klin Monbl Augenheilkd       Date:  2005-09       Impact factor: 0.700

8.  Neodymium-YAG laser surgery on experimental vitreous membranes.

Authors:  C A Puliafito; P J Wasson; R F Steinert; E S Gragoudas
Journal:  Arch Ophthalmol       Date:  1984-06

9.  Pars plana vitrectomy for persistent, visually significant vitreous opacities.

Authors:  W M Schiff; S Chang; N Mandava; G R Barile
Journal:  Retina       Date:  2000       Impact factor: 4.256

10.  Collagen fibril organisation in mammalian vitreous by freeze etch/rotary shadowing electron microscopy.

Authors:  K J Bos; D F Holmes; R S Meadows; K E Kadler; D McLeod; P N Bishop
Journal:  Micron       Date:  2001-04       Impact factor: 2.251

View more
  13 in total

1.  Persistent troublesome floaters necessitating the explantation of XtraFocus Pinhole IOL (Morcher).

Authors:  Prateek Agarwal; Samuel Edward Navon
Journal:  BMJ Case Rep       Date:  2019-04-08

2.  Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.

Authors:  Justin H Nguyen; Jeannie Nguyen-Cuu; Fei Yu; Kenneth M Yee; Jonathan Mamou; Ronald H Silverman; Jeffrey Ketterling; J Sebag
Journal:  Ophthalmology       Date:  2019-06-22       Impact factor: 12.079

Review 3.  Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.

Authors:  Harshini Chakravarthy; Vasudharani Devanathan
Journal:  J Mol Neurosci       Date:  2018-10-06       Impact factor: 3.444

4.  Evaluation of Available Online Information Regarding Treatment for Vitreous Floaters.

Authors:  Meghana Kalavar; Sasha Hubschman; Julia Hudson; Ajay E Kuriyan; Jayanth Sridhar
Journal:  Semin Ophthalmol       Date:  2021-02-18       Impact factor: 1.975

5.  Surgical Outcomes of 27-Gauge Pars PLana Vitrectomy for Symptomatic Vitreous Floaters.

Authors:  Zhong Lin; Rui Zhang; Qi Hua Liang; Ke Lin; Yu Shu Xiao; Nived Moonasar; Rong Han Wu
Journal:  J Ophthalmol       Date:  2017-11-29       Impact factor: 1.909

6.  miRNAs in the vitreous humor of patients affected by idiopathic epiretinal membrane and macular hole.

Authors:  Andrea Russo; Marco Ragusa; Cristina Barbagallo; Antonio Longo; Teresio Avitabile; Maurizio G Uva; Vincenza Bonfiglio; Mario D Toro; Rosario Caltabiano; Cesare Mariotti; Francesco Boscia; Mario Romano; Cinzia Di Pietro; Davide Barbagallo; Michele Purrello; Michele Reibaldi
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

7.  27-Gauge Vitrectomy for Symptomatic Vitreous Floaters with Topical Anesthesia.

Authors:  Zhong Lin; Nived Moonasar; Rong Han Wu; Robin R Seemongal-Dass
Journal:  Case Rep Ophthalmol       Date:  2017-01-20

8.  The Efficacy and Safety of YAG Laser Vitreolysis for Symptomatic Vitreous Floaters of Complete PVD or Non-PVD.

Authors:  Tiezhu Lin; Tongtong Li; Xinmei Zhang; Yannian Hui; Salissou Moutari; Emmanuel Eric Pazo; Guangzheng Dai; Lijun Shen
Journal:  Ophthalmol Ther       Date:  2021-11-15

Review 9.  Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy.

Authors:  Mark T Bolinger; David A Antonetti
Journal:  Int J Mol Sci       Date:  2016-09-07       Impact factor: 5.923

Review 10.  Many Faces of Renin-angiotensin System - Focus on Eye.

Authors:  Mervi Holappa; Heikki Vapaatalo; Anu Vaajanen
Journal:  Open Ophthalmol J       Date:  2017-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.